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Upregulation of Substance P in Low-Threshold Myelinated
Afferents IsNot Required for Tactile Allodynia in the Chronic
Constriction Injury and Spinal Nerve Ligation Models
David I. Hughes, Dugald T. Scott, John S. Riddell, and Andrew J. Todd
Spinal Cord Group, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom
It has been proposed that substance P and calcitonin gene-related peptide (CGRP) are upregulated in low-thresholdmyelinated primary
afferents after certain types of nerve injury, and that release of substance P from these afferents contributes to the resulting tactile
allodynia. To test this hypothesis, we looked for neuropeptides in A primary afferent terminals in the ipsilateral gracile nucleus and
spinal dorsal horn in three nerve injury models: sciatic nerve transection (SNT), spinal nerve ligation (SNL), and chronic constriction
injury (CCI).We also looked for evidence of neurokinin 1 (NK1) receptor internalization in the dorsal horn after electrical stimulation of
A afferents. We found no evidence of either substance P or CGRP expression in injured A terminals in the spinal cord in any of the
models. Although substancePwasnot detected in terminals of injured afferents in the gracile nucleus, CGRPwas expressed inbetween32
and68%of these terminals,with a significantly higher proportion in the SNLandCCImodels, comparedwith SNT. In addition,wedidnot
detect any A-evoked NK1 receptor internalization in neurons from laminas I, III, or IV of the dorsal horn in the CCI or SNL models.
These results do not support the proposal that substance P is present at significant levels in the terminals of injuredAprimary afferents
in neuropathic models. They also suggest that any release of substance P from injured A afferents is unlikely to activate NK1 receptors
in the dorsal horn or contribute to neuropathic pain.
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Introduction
Large myelinated (A) cutaneous primary afferent axons termi-
nate in the spinal dorsal horn, occupying an area that extends
from the inner part of lamina II (IIi) to lamina V, and some also
send branches to the gracile or cuneate nuclei (Brown, 1981;
Willis and Coggeshall, 2004; Todd and Koerber, 2005). Most of
these axons transmit information from low-threshold mechano-
receptors, and stimulation of A afferents generally gives rise to
nonpainful sensations (Torebjo¨rk et al., 1987). However, the tac-
tile allodynia that often develops after peripheral nerve injuries is
at least partly mediated by A afferents (Campbell et al., 1988;
Gracely et al., 1992; Ochoa and Yarnitsky, 1993).
Nerve injury results in substantial changes in neuropeptide
expression by unmyelinated (C) fibers [for example, downregu-
lation of substance P and calcitonin gene-related peptide (CGRP)
and upregulation of galanin] (Ho¨kfelt et al., 1994). Although
low-threshold myelinated afferents do not normally synthesize
neuropeptides, it is well established that they can upregulate neu-
ropeptide Y (NPY) after peripheral axotomy (Wakisaka et al.,
1991, 1992; Zhang et al., 1993).
It has been proposed that nerve injury can also lead to upregu-
lation of substance P in A afferents. Noguchi et al. (1995) re-
ported that, after spinal nerve transection, PPT (preprotachyki-
nin) mRNA, which codes for substance P, was present in large
dorsal root ganglion neurons, while substance P was detected in
large myelinated peripheral nerve fibers. They also found that
sciatic nerve transection (SNT) caused an increase in the level of
substance P in the gracile nucleus, although not in laminas III–IV
of the dorsal horn. Allen et al. (1999) failed to detect internaliza-
tion of the neurokinin 1 (NK1) receptor (a measure of substance
P release) after stimulating A fibers in chronically transected
sciatic nerves, and Malcangio et al. (2000) did not observe sub-
stance P release in spinal cord slices after stimulation of A fibers
in the same model. However, Malcangio et al. (2000) did find
A-evoked substance P release in rats that had undergone spinal
nerve lesions. Pitcher and Henry (2004) used a modification of
the chronic constriction injury (CCI) model (Bennett and Xie,
1988) and observed touch-evoked afterdischarges in dorsal horn
neurons that were apparently driven by myelinated afferents and
were blocked by NK1 receptor antagonists. These results suggest
that the extent of substance P upregulation in A afferents may
depend on the type and location of axonal injury. Because sub-
stance P excites nociceptive dorsal horn neurons (Salter and
Henry, 1991), it has been proposed that upregulation of the pep-
tide in A cutaneous afferents may contribute to allodynia after
certain types of nerve injury (Devor, 2005).
In this study, we used three nerve injury models [SNT, CCI,
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and spinal nerve ligation (SNL)] to look for evidence that central
terminals of A afferents contain and/or release substance P after
nerve injuries that give rise to tactile allodynia. Because it has
been suggested that CGRP is upregulated in A afferents after
nerve injury (Miki et al., 1998;Ma et al., 1999), we also looked for
CGRP in central terminals of these afferents.
Materials andMethods
All experiments were approved by the Ethical Review Process Applica-
tions Panel of the University of Glasgow, and were performed in accor-
dance with the European Community directive 86/609/EC and the
United Kingdom Animals (Scientific Procedures) Act 1986.
Animals and operative procedures. Experiments were performed on a
total of 24 adultmale SpragueDawley rats (Harlan, Loughborough, UK),
with body weights between 240 and 320 g. Surgical procedures were
performed on 17 of the rats to produce three distinct types of unilateral
peripheral nerve injury: SNT (n 5), CCI (n 6), and SNL (n 6). In
each of these cases, the surgery was performed under halothane anesthe-
sia. For SNT, the left sciatic nerve was exposed at midthigh level and a 5
mm length was removed between two ligatures. For CCI, four loose 4-0
chromic catgut ligatures were placed around the left sciatic nerve at
midthigh level (Bennett and Xie, 1988). For SNL, the left L5 spinal nerve
was tightly ligated 5 mm distal to the dorsal root ganglion with 4-0
Mersilk (Kim and Chung, 1992). All animals made an uneventful recov-
ery after surgery.
Behavioral testing. Rats that had undergone SNL were tested to detect
signs of tactile allodynia, whereas those with CCI were tested for tactile
allodynia and thermal hyperalgesia. In each case, the animals were tested
on preoperative days 6, 3, and 1, and on postoperative days 1, 4, 6, 8, 11,
and 14. Responses to thermal stimuli were measured with a Plantar An-
algesia Instrument (Ugo-Basile, Comerio, Italy) (Hargreaves et al., 1988)
as described previously (Polga´r et al., 2003) and differences between the
two sides were assessed with a one-tailed unpaired t test for each time
point. Tests for tactile allodynia were performed with a series of von Frey
filaments as described by Polga´r et al. (2005). The 50% paw withdrawal
threshold was calculated by using Dixon’s nonparametric test (Dixon,
1980; Chaplan et al., 1994), and differences between the two sides at each
time point were assessed with a one-tailed Mann–Whitney U test.
Transganglionic labeling of injured sciatic afferents. Two of the rats that
had undergone SNT were used to investigate the extent of NPY upregu-
lation in primary afferents in the gracile nucleus, to determine whether
NPY was a reliable marker for axotomized myelinated afferent terminals
in this region (see below). Eleven days after the SNTprocedure, theywere
reanesthetized with halothane and received injections of 3l of 1% chol-
era toxin B subunit (CTb) (Sigma, Poole, Dorset, UK) into the sectioned
left sciatic nerve. They were fixed by perfusion under terminal anesthesia
3 d later (see below).
Stimulation of primary afferents. Electrical stimulation of primary af-
ferents was performed in 10 cases: three CCI and three SNL rats, together
with four animals that had not undergone nerve injury operations (un-
operated rats). This was done to test whether substance P was released
from the stimulated afferents and would internalize NK1 receptors on
dorsal horn neurons. For the CCI and SNL rats, the stimulation was
performed on the 14th day after the operation. In each case, anesthesia
was induced with halothane and subsequently maintained by regular
doses of sodium pentobarbitone (Rhoˆne-Me´rieux, Harlow, Essex, UK;
10 mg/kg, i.v.), given as required. The depth of anesthesia was initially
assessed by monitoring the pedal withdrawal reflexes, the corneal reflex,
and blood pressure. The corneal reflex and blood pressure were moni-
tored throughout the duration of the experiment. Animals were then
paralyzed with Pancuronium bromide (Pavulon, Faulding, Leamington
Spa, UK; 0.3 mg/kg, i.v., every 40 min) and ventilated artificially with
anesthetic administered at a frequency commensurate with that required
before paralysis. Core temperature was maintained close to 38°C. Mean
blood pressure was always80 mmHg and PCO2 was maintained within
the range 4.0–4.5%.
A lumbar laminectomy was performed to expose spinal levels T13 to
S1, and either the left sciatic nerve or the left L5 dorsal root was exposed
and mounted in continuity on silver bipolar stimulating electrodes. In
the rats that had undergone SNL, the L5 dorsal root was stimulated at a
strength sufficient to activate A fibers (see below), whereas in the CCI
rats, the sciatic nerve was stimulated at A strength with the cathode
placed centrally,5 mm proximal to the lesion. In two unoperated rats,
the L5 dorsal root was stimulated at A strength (A controls), and in an
additional two unoperated rats the sciatic nerve was stimulated at a
strength sufficient to activate C fibers (C fiber controls). This last group
was used to confirm that the substance P released from C fibers caused
internalization of NK1 receptors in the dorsal horn. Stimulation at C
fiber strength was applied to the sciatic nerve (rather than the L5 dorsal
root) to avoid the possibility of direct stimulus spread to the spinal cord.
The exposed spinal cord, and nerve or dorsal root were covered in
warm mineral oil, and a silver ball electrode was placed on the lumbar
dorsal columns to record afferent volleys and cord dorsum potentials
(CDPs) evoked by afferent fiber stimulation. Electrical stimulation was
performed at least 1 h after placing the electrodes to allow for recycling of
any NK1 receptors that may have been internalized as a result of nerve
manipulation (Allen et al., 1999). To determine an appropriate stimulus
intensity for maximal activation of A afferents, we applied stimuli (du-
ration, 0.2 ms) to the nerve while monitoring the A-evoked CDP. A
stimulus intensity 20–30% above that found to evoke an A CDP of
maximal amplitude was used for subsequent stimulation. This method
was needed to ensure that all A afferents in the nerve were excited,
because the excitability of myelinated axons may alter after nerve injury.
The stimulus strength was up to 10 A for stimulation of the dorsal root
and up to 200 A for stimulation of the sciatic nerve. The difference in
stimulation intensity required at the two sites is at least partly attributable
to the much larger size of the sciatic nerve, compared with the L5 dorsal
root. Supramaximal A stimulation (0.2 ms duration) was applied for 5
min at a frequency of 10 Hz. For the C fiber controls, stimuli of 10 mA
(0.5 ms duration) were applied for 5 min at a frequency of 10 Hz. In all
cases, animals were maintained under anesthetic for 8 min after the end
of the electrical stimulation, because NK1 receptor internalization has
been found to be maximal at this time (Mantyh et al., 1995). They were
then fixed by perfusion (see below) under deep anesthesia.
Fixation and sectioning.All of the rats that had undergone nerve injury
operations were fixed by perfusion on the 14th day after the operation.
This time was chosen because it has been reported that upregulation of
substance P and CGRP in myelinated afferents in the gracile nucleus is
maximal at 14 d (Noguchi et al., 1995;Miki et al., 1998). Behavioral signs
of neuropathic pain are also well established at this time (Bennett and
Xie, 1988; Kim and Chung, 1992). The A and C fiber control groups
were also perfused at the end of the stimulation procedure, and an addi-
tional three unoperated rats were perfused to allow assessment of NK1
receptor internalization in naive animals. In all cases, rats were deeply
anesthetized with pentobarbitone and perfused through the left ventricle
with 1000 ml of fixative containing 4% freshly depolymerized formalde-
hyde. The L4 and L5 segments of spinal cord and/or the region of caudal
medulla containing the gracile nuclei were removed, notched to allow
identification of the two sides and postfixed at 4°C overnight. They were
then cut into 60-m-thick transverse sections with a vibratome. The
sections were incubated in 50% ethanol before being processed for
immunocytochemistry.
General features of immunocytochemistry and analysis. All immunocy-
tochemical procedures involved incubation of free-floating sections in
mixtures of primary antibodies for 48 h, followed by treatment with
combinations of species-specific fluorescent secondary antibodies for
24 h, in each case at 4°C. Secondary antibodies were all raised in donkey
and conjugated to either Alexa 488 (Invitrogen, Eugene, OR; 1:500) or
Rhodamine Red or Cy5 (Jackson ImmunoResearch, West Grove, PA;
1:100). All antibodies were diluted in PBS containing 0.3 M NaCl and
0.3% Triton X-100. In some cases, nuclear staining was performed with
4,6-diamidino-2-phenylindole (DAPI) or propidium iodide. Sections
were mounted in antifade medium (Vectashield; Vector Laboratories,
Peterborough, UK) and stored at20°C.
Sections were scanned with either a MRC 1024 or a Radiance 2100
confocalmicroscope (Bio-Rad,HemelHempstead, UK). All of the quan-
titative analysis was performed on sections scanned sequentially (to
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avoid fluorescent bleed-through) through a 60 oil immersion lens. For
the gracile nucleus, sections through the broadest part of the nucleus,
close to the level of the obex, were analyzed. Myelinated afferents in the
L5 dorsal root of the rat that terminate in lamina III extend throughout
the rostral one-half of the L5 segment and the whole of the L4 segment
(Rivero-Melia´n and Grant, 1990), and we therefore analyzed sections
from this region to ensure optimal sampling of L5 afferent terminals.
Sections were analyzed with Neurolucida for confocal software (Micro-
BrightField, Colchester, VT).
Detection of CTb and NPY in the gracile nucleus after transganglionic
labeling. Sections of caudal medulla from the two SNT rats that had
received injections of CTb into the transected sciatic nerve were incu-
bated in goat anti-CTb (List Biologic, Campbell, CA; 1:5000), guinea pig
anti-vesicular glutamate transporter 1 (VGLUT1) (Chemicon, Te-
mecula, CA; 1:20,000) and rabbit anti-NPY (Peninsula Laboratories, Bel-
mont, CA; 1:1000), and these were revealed with Alexa 488, Cy5, and
Rhodamine Red, respectively.
To confirm the presence of NPY in the central terminals of damaged
A afferent fibers, we initially obtained low-power scans (20 lens)
ipsilateral to the nerve injection to identify areas of CTb labeling in the
gracile nucleus. Two sections fromeach of the two rats were then scanned
through the 60 lens, and from the two animals 174 or 198 CTb-labeled
terminals were examined for NPY immunoreactivity, whereas 231 and
248 NPY-immunoreactive terminals were examined for CTb labeling. In
each case, the selection of boutonswasmadewhile the observer was blind
to the other type of immunostaining.
Substance P and CGRP in terminals of axotomized afferents. To look for
substance P and CGRP in the central terminals of injured myelinated
afferents, we reacted sections from the caudal medulla and from the L4
and L5 spinal segments from nine rats with a triple-labeling immunocy-
tochemicalmethod. The sections were taken from the three SNT rats that
had not received CTb injections, and from the three CCI and three SNL
rats that had not undergone electrical nerve stimulation.
Sections were incubated in either of the following: (1) guinea pig anti-
VGLUT1 (1:20,000), rabbit anti-NPY (1:1000), andmonoclonal rat anti-
substance P (Sera-Lab, Crawley Down, UK; 1:100), or (2) guinea pig
anti-VGLUT1 (1:20,000), sheep anti-NPY (Chemicon; 1:100), and rabbit
anti-CGRP (Affiniti Research Products, Exeter, UK; 1:1000). These were
revealed with Cy5, Rhodamine Red, and Alexa 488, respectively.
Sections of caudal medulla and lumbar spinal cord (five sections from
each region for each antibody combination per animal) were scanned
through areas in which NPY upregulation was evident. Injured A affer-
ents in the gracile nucleus were identified by the presence of NPY (see
below), and between 122 and 277 of these were selected from each animal
for each antibody combination. The selected boutons were then exam-
ined to determine whether they contained substance P or CGRP immu-
noreactivity. For the spinal cord, boutons in laminas IIi and III that
belonged to injured myelinated afferents, identified by the presence of
both NPY and VGLUT1 immunoreactivity, were selected (between 63
and 344 from each rat for each antibody combination) and examined for
substance P or CGRP immunoreactivity. In all cases, boutons were se-
lected before immunostaining for substance P or CGRP was viewed.
In addition, a search was made for both substance P and CGRP in
VGLUT1-immunoreactive boutons in the gracile nucleus (in three sec-
tions per animal) and for these peptides in boutons that contained either
NPY or VGLUT1 in laminas IIi and III of the spinal cord (three to five
sections per animal).
Investigation of NK1 receptor internalization after nerve stimulation.
Sections from the L4 and L5 spinal segments of all 10 rats that had
undergone electrical nerve stimulation (three CCI, three SNL, two A
control, two C fiber control) and from three additional naive rats were
processed to reveal the NK1 receptor. They were incubated in rabbit
anti-NK1 receptor (Sigma; 1:10,000), whichwas revealedwith Alexa 488,
and were then stained with DAPI or propidium iodide (Todd et al.,
1998).
To determine whether selective activation of A fibers after CCI and
SNL released sufficient substance P to internalize NK1 receptors on lam-
ina I neurons, we examined two sections from each of the three CCI and
three SNL rats. Tissue from the two A and two C fiber control animals
and from the three naive rats was also analyzed in the same way. Three
adjacent but nonoverlapping fields fromwithin the medial two-thirds of
lamina I were scanned through a 60 lens (78 optical sections at a z-step
of 0.45 m) from both dorsal horns of each spinal cord section. Image
stacks were initially analyzed to identify all NK1 receptor-expressing
lamina I neurons for which the nucleus was entirely contained within the
stack of confocal images. For each of these cells, the total number of NK1
receptor-immunoreactive endosomes contained within the soma (be-
tween sections corresponding to the top and bottomof the nucleus) were
identified by using criteria described previously (Mantyh et al., 1995;
Allen et al., 1999; Honore´ et al., 2000). Endosomes were defined as in-
tensely immunoreactive intracellular organelles between 0.2 and 0.8 m
in diameter that were not part of the external cellmembrane or in contact
with the cell nucleus. The mean number of endosomes per cell body was
determined for each side of each animal, and these results were compared
by using a one-way ANOVA with Tukey’s pairwise comparisons.
We also analyzed large NK1 receptor-immunoreactive neurons in
laminas III and IV in the naive animals and on each side of the A
control, C fiber control, CCI, and SNL animals (7–14 sections per ani-
mal). All neurons of this type for which the entire nucleus was contained
in a single section were identified, and the number of endosomes in each
cell body was counted.
For both parts of this analysis, the observer was blind to the experi-
mental group to which each section belonged.
Results
Behavior
All CCI and SNL rats showed similar changes in posture, regard-
less of the type of surgery performed: the affected pawwas held in
either an inverted or everted position, with toes plantar-flexed.
The foot was often held in the air, and animals avoided prolonged
weight bearing on the affected hindpaw.
Results of the tests for thermal hyperalgesia and tactile allo-
dynia are shown in Figure 1. In the animals with CCI, withdrawal
latencies of the affected hindpaw to radiant heat were signifi-
cantly reduced compared with those of the contralateral paw
from postoperative day 4 up to day 14 ( p  0.005, one-tailed
unpaired t test) (Fig. 1a). In these animals, there was a moderate
reduction in 50% withdrawal threshold of the affected hindpaw
to mechanical stimulation. This was significantly different from
that of the contralateral side from day 4 onward, and reached a
threshold of10 g on days 11 and 14, at which times the differ-
ence between the two sides was highly significant ( p  0.005,
one-tailed Mann–Whitney U test). In the animals with SNL, the
50%withdrawal threshold of the affected hindpaw tomechanical
stimulation showed a greater reduction than that seen in the CCI
rats, with values4 g on days 6, 11, and 14 (Fig. 1c). There was a
highly significant difference between the responses of the two
hindpaws from postoperative day 4 up to day 14 ( p  0.005,
one-tailed Mann–Whitney U test).
Transganglionic labeling of sectioned sciatic afferents
In the dorsal horn, the central terminals of all low-threshold my-
elinated sciatic nerve afferents (but not those of A nociceptors)
express VGLUT1 (Todd et al., 2003), and many of these contain
NPY after nerve injury (Wakisaka et al., 1991). Although
VGLUT1 is moderately depleted in the central terminals of axo-
tomized myelinated afferents in the dorsal horn by 2 weeks after
nerve injury, it can still be detected in the great majority of these
terminals (Hughes et al., 2004). In the present study, we observed
many axonal boutons that showed both VGLUT1 and NPY im-
munoreactivity in laminas IIi and III in all nerve-injured animals
(see below). These presumably correspond to axotomized low-
threshold myelinated afferents. NPY was also strongly upregu-
lated in the ipsilateral gracile nucleus after each type of nerve
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injury (Figs. 2d, 3a,b).However, we found a substantial reduction
of VGLUT1 in the corresponding region (Fig. 2a,b), and the great
majority of NPY-immunoreactive boutons did not show detect-
able VGLUT1 immunoreactivity (Fig. 2f–i). The mean percent-
ages of NPY-immunoreactive terminals in the ipsilateral gracile
nucleus that were also VGLUT1 immunoreactive in SNT, CCI,
and SNL animals were 20.3 (range, 2.3–34.8), 17.1 (9.5–24.8),
and 17.4 (1.5–37.9), respectively. Because NPY is only seen in the
gracile nucleus after axotomy (Zhang et al., 1993), themost likely
explanation for this is that VGLUT1 is depleted to below the
threshold for detection in the terminals of most axotomized my-
elinated afferents in this region. To confirm that the NPY was
located in axotomized afferents, we compared immunostaining
for CTb and NPY in the gracile nucleus in the two SNT rats that
had received injections of CTb into the transected sciatic nerve.
The two types of immunostaining occupied corresponding areas
within the nucleus (Fig. 2c,d), andmost of the terminals that were
labeled with CTb in each animal were found to express NPY (93
and 86%), while the majority of NPY terminals were labeled
with CTb (80 and 94%). However, few of the NPY/CTb-
immunoreactive boutons were stained with the VGLUT1 anti-
Figure 1. Results of behavioral tests on the CCI and SNL animals.a, Means and SEMs for paw
withdrawal thresholds to thermal stimulation of the contralateral (contra) and ipsilateral (ipsi)
hindpaws in the CCI animals (n  6) on different preoperative and postoperative days. b,
Means and SDs for 50% withdrawal threshold of the ipsilateral and contralateral hindpaw to
application of von Frey hairs in the CCI rats (n 6). c, Means and SDs for 50% withdrawal
threshold of the ipsilateral and contralateral hindpaw to application of von Frey hairs in the SNL
rats (n6). In each case, significantdifferencesbetweenhindpawsare shownas follows: *p
0.05, **p 0.01, ***p 0.005 (one-tailed unpaired t test for thermal stimulation; one-tailed
Mann–Whitney U test for tactile stimulation).
Figure 2. Central patterns of labeling for VGLUT1, CTb, andNPY in the gracile nuclei 2weeks
after unilateral SNTand subsequent CTb injection into the lesionednerve.a,b, VGLUT1 is shown
in the ipsilateral (a) and contralateral (b) gracile nucleus. c,d, ande showCTb,NPY, andmerged
CTb/NPY labeling in the ipsilateral nucleus, and f–i show a high-magnification view from the
ipsilateral nucleus to reveal CTb (f ), NPY (g), VGLUT1 (h), and all three types of immunostaining
(i). The outer dashed lines in a and c– e, and the dashed line in b represent the outline of the
gracile nucleus. The inner dashed line ina and c– e indicates the region inwhich themajority of
NPY-immunoreactive axons were located (as shown in d). On the ipsilateral side, there is a
reduction in VGLUT1 labeling in the area outlined by the inner dashed line (a) compared with
that seen on the contralateral side (b), and CTb-labeled primary afferent terminals are present
in the same area (c). CTb labeling and NPY expression are found in directly overlapping areas in
the ipsilateral gracile nucleus (e). High-magnification views show colocalization of CTb (f ) and
NPY (g) in lesioned primary afferent terminals (some indicated by arrows), but these have no
detectable VGLUT1 (h). Scale bars: a–e, 100m; f–i, 10m.
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body (Fig. 2f–i). NPY was not detected in the gracile nucleus on
the contralateral side after any of the nerve injuries (Fig. 3b).
Substance P and CGRP in the ipsilateral gracile nucleus after
nerve injury
Although we found limited coexistence of VGLUT1 and NPY in
axon terminals in the ipsilateral gracile nucleus after nerve injury,
the results obtained from the CTb-injected SNT rats indicate that
at least the great majority of NPY-immunoreactive boutons in
the ipsilateral gracile nucleus belong to axotomized primary af-
ferents. We therefore used the presence of NPY to identify axo-
tomized primary afferent terminals in the gracile nucleus after
each type of nerve injury.
A few boutons and fibers with strong CGRP immunoreactiv-
ity were found scattered throughout both the ipsilateral and con-
tralateral gracile nuclei in all nerve-injured animals, and the den-
sity of these did not appear to differ between the two sides (Fig.
3c,d). This distribution resembles that seen in the gracile nucleus
of normal rats and cats (Fabri and Conti, 1990; Ma and Bisby,
1998). In each nerve injury model, many of the NPY-
immunoreactive boutons in the ipsilateral gracile nucleus also
showed CGRP immunoreactivity (Fig. 3). However, the CGRP
immunostaining of these terminals was considerablyweaker than
that seen in the scattered terminals described above. The mean
percentages of NPY-immunoreactive terminals that were also
CGRP immunoreactive were 31.5 for SNT rats, 67.7 for CCI rats,
and 56.1 for SNL rats (Table 1). One-way ANOVA with post hoc
Tukey’s pairwise comparisons showed that the frequency of ex-
pression of CGRP in lesioned terminals after SNT was signifi-
cantly different from those after CCI and SNL ( p 0.005).
Although strong staining for substance P was seen in various
structures in themedulla, including the spinal trigeminal nucleus
and the nucleus of the solitary tract, we found very few substance
P-immunoreactive profiles in the gracile nucleus on either side
after nerve injury (Fig. 4). Very weak substance P immunoreac-
tivity was observed in a small proportion of NPY-
immunoreactive boutons (data not shown). The mean percent-
ages of NPY-immunoreactive terminals that were substance P
immunoreactive were 0.2 for SNT rats, 1.5 for CCI rats, and 1.9
for SNL rats (Table 1). One-way ANOVA with post hoc Tukey’s
pairwise comparisons showed these values were not significantly
different. Neither substance P nor CGRP immunoreactivity was
detected in VGLUT1 terminals that did not express NPY.
In these experiments, we used a well characterized monoclo-
nal substance P antibody (Cuello et al., 1979), but this was differ-
ent from that used by Noguchi et al. (1995). To confirm that this
Figure 3. NPY and CGRP immunostaining in the gracile nuclei 14 d after unilateral L5 spinal
nerve ligation. a–i, NPY immunoreactivity (a, b, g), CGRP immunoreactivity (c, d, h), and
merged images (e, f, i) from ipsilateral (a, c, e, g–i) and contralateral (b, d, f ) gracile nuclei are
shown. The outer dashed lines in a, c, and e, and the dashed lines in b, d, and f represent the
outline of the gracile nucleus. Unilateral upregulation of NPY is seen in the ipsilateral nucleus
(areas outlined by inner dashed lines in a). Scattered CGRP-immunoreactive axons are present
in both gracile nuclei, but in the area of NPY upregulation numerous weakly positive CGRP
terminals are present (c). The merged images show that many of the NPY-immunoreactive
profiles also contain CGRP (e, i). The asterisks in c and d show CGRP-immunoreactive axons in
the solitary tract. Scale bars: a–f, 100m; g–i, 10m.
Table 1. CGRP and substance P expression in NPY-positive boutons in the ipsilateral
gracile nucleus in different nerve injury models
CGRP Substance P
Model Animal NPY boutons tested % Positive NPY boutons tested % Positive
SNT 1 128 39.8 191 0
2 169 26.7 209 0
3 146 28.1 205 0.5
Mean 31.5 0.2
CCI 1 221 71.9 169 0
2 159 71.1 210 2.4
3 180 60.0 277 2.2
Mean 67.7 1.5
SNL 1 129 50.4 193 1.6
2 165 55.8 133 3.0
3 122 62.3 200 1.0
Mean 56.1 1.9
Figure 4. a, b, Substance P immunostaining in the ipsilateral (a) and contralateral (b) grac-
ile nuclei 14 d after unilateral L5 spinal nerve ligation. The outer dashed line ina and the dashed
line in b represent the outline of the gracile nucleus. NPY was upregulated in the ipsilateral
gracile nucleus in the region outlined by the two inner dashed lines (data not shown). Very few
substance P-immunoreactive profiles were seen in either gracile nucleus, and there was no
detectable upregulation of substance P in the areas in which NPY immunostainingwas present
(a). The asterisks ina andb show substance P-immunoreactive axons in the solitary tract. Scale
bar, 100m.
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did not account for the discrepancy, we also reacted some sec-
tions with the antibody used by Noguchi et al. (1995) and re-
vealed this with immunofluorescence and immunoperoxidase
methods. However, we saw no evidence of increased substance P
immunoreactivity in the ipsilateral gracile nucleus with either
method.
Substance P and CGRP in the ipsilateral dorsal horn after
nerve injury
Low-magnification examination of spinal cord sections from
SNT and CCI animals showed that NPY was upregulated in lam-
inas IIi and III, especially in the central part of the ipsilateral
dorsal horn, resembling the pattern that has been described after
sciatic nerve transection (Wakisaka et al., 1991; Zhang et al.,
1993). In SNL rats, the region of NPY upregulation extended
more laterally (Fig. 5c,d). In all three models, there was a modest
depletion of VGLUT1 from laminas IIi–III in the region corre-
sponding to that of increasedNPY, and therewas also a reduction
of substance P and CGRP immunostaining from the superficial
dorsal horn (Fig. 5).
As stated above, many of the NPY-immunoreactive boutons
in laminas IIi and III were also VGLUT1 immunoreactive. How-
ever, none of these was immunoreactive with antibody against
either substance P or CGRP (Fig. 6). Themean numbers of NPY/
VGLUT1-immunoreactive terminals per animal that were exam-
ined for CGRP immunoreactivity in the SNT, CCI, and SNL
groups were 242, 220, and 183, respectively (n  3 rats for each
model). The corresponding numbers per animal examined for
substance P immunoreactivity were 299, 246, and 154. Substance
P and CGRP were very seldom observed in boutons that con-
tainedVGLUT1but notNPY (0 of 1160 for substance P, 3 of 1260
for CGRP; data pooled for three SNT, three CCI, and three SNL
rats) or in those that contained NPY and not VGLUT1 (1 of 1290
for substance P, 5 of 1100 for CGRP; data pooled for three SNT,
three CCI, and three SNL rats).
NK1 receptor internalization after electrical
nerve stimulation
In naive rats, the pattern of NK1 receptor immunoreactivity in
the dorsal horn was similar to that described previously (Nakaya
et al., 1994; Brown et al., 1995). Immunostainingwas observed on
the surfaces of many cell bodies and dendrites in lamina I and on
scattered large neurons with cell bodies in laminas III or IV and
dendrites that entered the superficial dorsal horn. Although NK1
receptor-immunoreactive cell bodies were occasionally seen in
lamina II, these were invariably small and very weakly stained. A
similar distribution of NK1 receptor immunostaining was ob-
served in the CCI and SNL rats, although in these animals the
staining appeared to be stronger on the side ipsilateral to the
nerve injury.
After nerve stimulation at A strength, the sections from CCI
and SNL animals, as well as those from the A control rats, did
not show any signs of NK1 receptor internalization in lamina I
(Fig. 7). The mean numbers of endosomes observed in the se-
lected NK1 receptor-immunoreactive cell bodies in lamina I in
the different experimental groups are shown in Table 2. The
mean numbers of endosomes per cell on the ipsilateral side in the
CCI and SNL models were 1.0 and 0.6, respectively, and these
were similar to the values for the contralateral sides in these ani-
mals, each side of the A control group, and the naive rats. None
of the NK1 receptor-immunoreactive lamina I cells from either
side of any of the CCI, SNL, A control and naive animals were
classified as having undergone internalization (20 or more so-
matic endosomes per cell) (Mantyh et al., 1995). In contrast, on
the ipsilateral side in the C fiber control group, all of the NK1
receptor lamina I neurons examined showed numerous endo-
somes, and were classified as having undergone internalization
(Table 2, Fig. 7b). One-way ANOVA with post hoc Tukey’s pair-
wise comparisons showed that the difference between the ipsilat-
eral side of the C fiber controls and all other groups was signifi-
cant ( p 0.001), whereas no significant difference was detected
between any of the other groups.
Results of the analysis of the lamina III–IV NK1 receptor-
immunoreactive neurons are shown in Table 3, and examples of
immunostaining are shown in Figure 8. Very few endosomes
were observed in these neurons on either side in any of the groups
examined, except for the ipsilateral side of the C fiber controls, in
which all of the cells were classified as having undergone inter-
nalization. Again, one-way ANOVA with post hoc Tukey’s pair-
wise comparisons showed that the difference between the ipsilat-
eral side of the C fiber controls and all other groups was
significant ( p  0.001), whereas no significant difference was
detected between any of the other groups.
Discussion
There have been several reports that substance P is upregulated in
A afferents after nerve injury (Marchand et al., 1994; Noguchi et
al., 1994, 1995; Fukuoka et al., 1998) or inflammation (Neumann
Figure 5. VGLUT1, NPY, and substance P immunostaining in the lumbar spinal cord 14 d
after unilateral L5 spinal nerve ligation. a–h, The figure shows VGLUT1 (a, b), NPY (c, d),
substance P (SP) (e, f ), and merged images (g, h) on the ipsilateral (ipsi) (a, c, e, g) and
contralateral (contra) (b,d, f,h) sides. VGLUT1 staining reveals abandof immunoreactive axons
that occupies the deeper part of the dorsal horn (extending ventrally from lamina IIi), and the
staining is weaker on the ipsilateral side because of depletion of VGLUT1 from injured primary
afferent terminals. NPY immunostaining is normally concentrated in laminas I–II (d), but is
increased in a region just ventral to this, corresponding to lamina III, on the ipsilateral side (c).
Substance P is normally present in laminas I–II (f ), but there is reduced immunostaining on the
ipsilateral side (e). Scale bar, 100m.
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et al., 1996). Although Allen et al. (1999) failed to detect sub-
stance P release from A afferents after SNT or inflammation,
two studies have suggested that this occurs in neuropathicmodels
(Malcangio et al., 2000; Pitcher and Henry, 2004).
Our results suggest that, although nerve injury does induce
modest upregulation of CGRP in A afferents in gracile nucleus,
neither SNL nor CCI leads to detectable levels of substance P in
A terminals in gracile nucleus or dorsal horn. We also found
that these injuries do not result inNK1 receptor internalization in
dorsal horn neurons after stimulation of injured A fibers.
Identification of terminals of injured afferents
A terminals can be revealed with CTb, a selective marker for
myelinated afferents (Robertson andGrant, 1985; Rivero-Melia´n
and Grant, 1990). However, we avoided using CTb in case this
interfered with transport of substance P or CGRP. We therefore
tested the suitability of NPY as a marker for terminals of injured
myelinated afferents. VGLUT1 is found in central terminals of all
low-threshold myelinated afferents in spinal cord and is not nor-
mally colocalized with NPY (Todd et al., 2003). Although
VGLUT1 is depleted after nerve injury, it can still be detected in
mostmyelinated afferent terminals in laminas III–V 2weeks after
SNT (Hughes et al., 2004). Colocalization
of VGLUT1 andNPY therefore allowed us
to identify boutons belonging to injured
myelinated afferents. It is likely that
VGLUT1 was depleted to below detection
threshold in terminals of some axoto-
mized A afferents in the dorsal horn.
However, our failure to find substance P
or CGRP in significant numbers of
NPY/VGLUT1 boutons suggests that
neither of these peptides was upregulated
in these terminals.
NPY is not normally expressed in the
gracile nucleus, but appears after nerve in-
jury in boutons presumed to belong to
damaged myelinated afferents (Zhang et
al., 1993). However, VGLUT1 was de-
tected in only 17–20% of NPY-containing
terminals in nerve-injured animals. To
confirm that NPY-containing axons were
primary afferents, we injected CTb into
the transected sciatic nerve in two rats and
found that most (80–94%) were CTb im-
munoreactive, and90% of CTb-labeled
afferents expressed NPY. Unmyelinated
afferents can transport CTb after nerve in-
jury (Tong et al., 1999; Bao et al., 2002;
Shehab et al., 2003). However, these
project sparsely to the gracile nucleus
(Giuffrida and Rustioni, 1992) and most
NPY-expressing axotomized afferents are
thought to have myelinated axons (She-
hab et al., 2003). It is therefore likely that
most (if not all) NPY-immunoreactive
boutons in the gracile nucleus belonged to
damaged myelinated afferents, and that
NPY was expressed by the great majority
of these.
Comparison with previous
anatomical studies
Two approaches have been used to investigate substance P and
CGRP upregulation in axotomized myelinated afferents: in situ
hybridization and immunocytochemistry. Several studies have
demonstrated increased mRNA for these peptides in large dorsal
root ganglion cells after nerve injury, and at least some of these
cells project to the gracile nucleus (Marchand et al., 1994; Nogu-
chi et al., 1994, 1995; Fukuoka et al., 1998; Miki et al., 1998).
Immunocytochemical findings are less clearcut. After SNT,
Noguchi et al. (1995) reported increased substance P immunore-
activity in ipsilateral gracile nucleus, but no change in laminas
III–IV of the dorsal horn, and Miki et al. (1998) found increased
CGRP immunoreactivity in both areas after spinal nerve transec-
tions. However, Ma and Bisby (1998) showed increased CGRP in
ipsilateral gracile nucleus, but depletion from deep dorsal horn
after SNT or CCI.
We observed weak CGRP immunoreactivity in many NPY-
containing axons in ipsilateral gracile nucleus after nerve injury.
The proportion was higher after CCI and SNL, which suggests
that this may have a role in neuropathic pain. However, we saw
very little staining for substance P in the gracile nucleus after any
nerve injury.
The situation in spinal cord is complicated by the presence of
Figure 6. VGLUT1, NPY, substance P (SP), and CGRP immunolabeling in boutons in lamina III of the ipsilateral lumbar spinal
cord after unilateral L5 spinal nerve ligation. a–d show a single field scanned for VGLUT1, NPY, and substance P. NPY and VGLUT1
are colocalized in several boutons (some indicated with arrows), which belong to injured myelinated afferents. However, sub-
stance P immunoreactivity is not present in any of these (c,d).e–h showanother field scanned for VGLUT1,NPY, andCGRP. Again,
NPYandVGLUT1are colocalized in certain boutons (some indicatedwith arrows), but these donot contain CGRP immunoreactivity
(g, h). Images were obtained from stacks of five (a–d) or three (e–h) optical sections at 0.5m z-separation. Scale bar, 5m.
Figure 7. NK1 receptor immunostaining in lamina I after electrical nerve stimulation. Sections were scanned to reveal NK1
receptor (green) and DAPI (red). a and b are taken from unoperated animals stimulated at A and C fiber strength, respectively.
c andd are fromanimals that hadundergone CCI or SNL14dpreviously andwere stimulated at A strength. In each case, the inset
shows NK1 receptor immunostaining on one of the cells from the main image (identified with an asterisk) at a higher magnification.
Significant internalizationof theNK1receptor (indicatedbythepresenceofnumerousendosomes) isonlyseen inthecase inwhichCfibers
were stimulated (b). Each image shows a projection of three optical sections at 0.45m z-spacing. Scale bar, 10m.
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substance P and CGRP in fine-diameter afferents, some of which
terminate in deep laminas, and of substance P in nonprimary
axons. By examining boutons with both VGLUT1 and NPY, we
were able to exclude these populations and show that none of
those belonging to injuredmyelinated afferents contained detect-
able levels of either peptide. Because myelinated afferents that
terminate in gracile nucleus are a subpopulation of those in dor-
sal horn, our results suggest that different boutons belonging to
the same afferent differ in terms of peptide upregulation and
VGLUT1 depletion.
NK1 receptor internalization
Although immunocytochemistry failed to show substance P in
myelinated afferent terminals in dorsal horn, peptide release
could occur at a rate preventing accumulation in terminals. We
therefore looked for NK1 receptor internalization after A stim-
Table 2. Numbers of endosomes in lamina I NK1 receptor-immunoreactive neurons
Ipsilateral Contralateral
Model Animal Cells sampled Mean number of endosomes per cell % Cells internalized Cells sampled Mean number of endosomes per cell % Cells internalized
Naive 1 40 0.5 0
2 43 0.6 0
3 52 0.5 0
Mean 0.5 0
A control 1 24 2.9 0 37 0.9 0
2 32 1.8 0 41 0.9 0
Mean 2.3 0 0.9 0
A CCI 1 19 1.0 0 25 1.2 0
2 38 0.6 0 31 1.7 0
3 43 1.3 0 35 1.1 0
Mean 1.0 0 1.3
A SNL 1 39 1.0 0 40 1.4 0
2 50 0.2 0 37 0.1 0
3 36 0.6 0 47 0.7 0
Mean 0.6 0 0.7 0
C control 1 31 117.8 100 37 0.8 0
2 32 106.8 100 22 0.8 0
Mean 112.3 100 0.8 0
This table shows the numbers of endosomes identified in cell bodies of the selected lamina I NK1 receptor-immunoreactive neurons. Naive animals received no electrical stimulation, and results from the two sides of the spinal cords of these
animalswerepooled. All other groupswere stimulated atA strengthon the ipsilateral side, except for the “C control” group,whichwere stimulated at C fiber strengthon the ipsilateral side. For additional details, seeMaterials andMethods.
Cellswith20endosomesweredefinedas “internalized.”One-wayANOVAwithpost hoc Tukey’s pairwise comparisons showed that thedifferencebetween the ipsilateral side of the C control groupandall other sides/groupswas significant
(p 0.001), whereas no difference was detected between other sides or groups.
Table 3. Numbers of endosomes in NK1 receptor-immunoreactive neurons in laminas III–IV
Ipsilateral Contralateral
Model Animal Cells sampled Mean number of endosomes per cell % Cells internalized Cells sampled Mean number of endosomes per cell % Cells internalized
Naive 1 7 1.9 0
2 6 0.7 0
3 15 0.5 0
Mean 1 0
A control
1 6 4.2 0 11 2 0
2 9 2.3 0 7 1.7 0
Mean 3.2 0 1.9 0
A CCI 1 8 0.4 0 7 0 0
2 7 1.4 0 4 2 0
3 10 2.1 0 6 2.7 0
Mean 1.3 0 1.6 0
A SNL 1 13 3.2 0 8 0.6 0
2 7 0.3 0 7 0.6 0
3 8 1.4 0 7 4 0
Mean 1.6 0 1.7 0
C control 1 8 221 100 8 4.3 0
2 9 265.7 100 8 2.9 0
Mean 243 100 3.6 0
This table shows the numbers of endosomes identified in cell bodies of the lamina III–IV NK1 receptor-immunoreactive neurons. Naive animals received no electrical stimulation, and results from the two sides of the spinal cords of these
animalswere pooled. All other groupswere stimulated at A strength on the ipsilateral side, except for the C control group,whichwere stimulated at C fiber strength on the ipsilateral side. For additional details, seeMaterials andMethods.
Cells with20 endosomeswere defined as internalized. One-way ANOVAwith post hoc Tukey’s pairwise comparisons showed that the difference between the ipsilateral side of the C control group and all other sides/groupswas significant
(p 0.001), whereas no difference was detected between other sides or groups.
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ulation in different nerve injury models. We examined two pop-
ulations of cells with high levels of NK1 receptor, neurons in
laminas I and III/IV. All of the lamina III/IV and many of the
lamina I cells are projection neurons (Todd et al., 2000; Spike et
al., 2003). The lamina III/IV cells are located within the termina-
tion zone of A afferents and probably receive synaptic input
from these axons (Naim et al., 1998). Although central arbors of
A afferents only extend dorsally to lamina IIi, this is100 m
from lamina I. For both populations, we saw no increase in the
number of endosomes after A stimulation in CCI or SNL rats.
This suggests that any release of substance P from A afferents
after these injuries is below the level needed to activate significant
numbers of NK1 receptors on projection neurons. A possible
reason for the difference between our results and those of Malca-
ngio et al. (2000) is that they ligated three spinal nerves rather
than one. However, our SNL rats showed clear signs of tactile
allodynia, which cannot be explained by release of substance P
from A afferents.
Substance P and allodynia in neuropathic pain
There has been considerable debate about the mechanisms that
underlie tactile allodynia after nerve injury. There is evidence that
this is mediated, at least in part, by A afferents in both human
(Campbell et al., 1988; Gracely et al., 1992; Ochoa and Yarnitsky,
1993) and rat (Field et al., 1999). Several studies have shown that
NK1 receptor antagonists reduce tactile allodynia after nerve in-
jury (Campbell et al., 1998; Cumberbatch et al., 1998; Cahill and
Coderre, 2002), and this has led to the suggestion that substance
P upregulation in myelinated low-threshold afferents is at least
partially responsible. Two possible explanations based on this
assumption have been proposed.Devor (2005) has suggested that
release of the peptide from ectopically firing axotomized A af-
ferents could trigger and maintain central sensitization of dorsal
horn neurons, which would amplify tactile input leading to allo-
dynia. In contrast, Pitcher and Henry (2004) have argued that
neuropathy induces substance P synthesis inmyelinated afferents
that retain their peripheral terminations, and that peptide release
in the dorsal horn after activation of these afferents contributes
directly to tactile allodynia.
Our data strongly suggest that, although there may be de novo
synthesis of substance P in cell bodies of axotomized A afferents
(Noguchi et al., 1994, 1995; Weissner et al., 2006), this does not
result in significant levels of the peptide being present in, or re-
leased from, their central terminals. It is possible that some A
afferents that are damaged but not axotomized in the CCI model
fail to upregulate NPY, and would therefore have been excluded
from the main part of our analysis. However, because we never
observed substance P immunoreactivity in boutons that con-
tained VGLUT1 but not NPY in laminas IIi–III in thismodel, it is
extremely unlikely that central terminals of such afferents would
contain substance P.
A possible explanation for the effect of NK1 receptor antago-
nists described above is that there are two distinct forms of tactile
allodynia, static and dynamic, which involve different types of
primary afferent (Ochoa and Yarnitsky, 1993; Field et al., 1999;
Gonzalez et al., 2000). It is generally agreed that dynamic allo-
dynia results from activation of A afferents, whereas the static
form appears to be mediated by C fibers (Ochoa and Yarnitsky,
1993) or capsaicin-sensitive A fibers (Field et al., 1999). The
studies that found antiallodynic effects of NK1 receptor antago-
nists used von Frey hairs, and will therefore have detected static
allodynia (Campbell et al., 1998; Cumberbatch et al., 1998; Cahill
andCoderre, 2002). Interestingly, Gonzalez et al. (2000) reported
that, whereas static allodynia after CCI was partially blocked by a
NK1 receptor antagonist, dynamic allodynia was not affected.
They concluded that upregulation of substance P in A afferents
was unlikely to have occurred in this model. Pitcher and Henry
(2004) observed NK1 receptor-mediated afterdischarges in rat
dorsal horn neurons in response to innocuous pressure stimuli,
similar to those that generate static allodynia. The simplest expla-
nation of these findings is that substance P release from A
and/or C fibers contributes to static allodynia, but that there is
little or no release of substance P from the A afferents that evoke
dynamic allodynia.
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